Epigenetic Gene Silencing in the Wnt Pathway in Breast Cancer

Overview

Journal Epigenetics

Specialty Genetics

Date 2008 Apr 10

PMID 18398311

Citations 64

Authors

George J Klarmann

Amy Decker

William L Farrar

Affiliations

Soon will be listed here.

Abstract

Breast cancer is one of the most common malignancies in women. Despite advances in treatment of endocrine-dependent tumors, the complete molecular basis of transformation is still unknown. What is clear is that a variety of genetic lesions and epigenetic modifications are present in the neoplasm. Disregulation of several signaling pathways is known to be associated with breast cancer development, among them is the wingless and integration site growth factor (Wnt) pathway. While genetic mutations of certain components of this pathway, such as APC, are significant contributing factors for colorectal cancers, they are typically not the predominate mechanism associated with breast cancer. Instead, it appears that DNA hypermethylation leads to aberrant regulation of the Wnt pathway in breast cancer, and as such, this review focuses on the epigenetic regulation of Wnt pathway components in breast cancer.

Citing Articles

Cellular Epigenetic Targets and Epidrugs in Breast Cancer Therapy: Mechanisms, Challenges, and Future Perspectives.

Alalhareth I, Alyami S, Alshareef A, Ajeibi A, Al Munjem M, Elfifi A Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006021 PMC: 11858621. DOI: 10.3390/ph18020207.

DOT1L Mediates Stem Cell Maintenance and Represents a Therapeutic Vulnerability in Cancer.

Kurani H, Kurani H, Slingerland J Cancer Res. 2024; 85(5):838-847.

PMID: 39700409 PMC: 11873724. DOI: 10.1158/0008-5472.CAN-24-3304.

BMP Stimulation Differentially Affects Phosphorylation and Protein Stability of β-Catenin in Breast Cancer Cell Lines.

Ilhan M, Hastar N, Kampfrath B, Spierling D, Jatzlau J, Knaus P Int J Mol Sci. 2024; 25(9).

PMID: 38731813 PMC: 11083028. DOI: 10.3390/ijms25094593.

Influence of Long Non-Coding RNA in the Regulation of Cancer Stem Cell Signaling Pathways.

Sonawala K, Ramalingam S, Sellamuthu I Cells. 2022; 11(21).

PMID: 36359888 PMC: 9656902. DOI: 10.3390/cells11213492.

The metabolic addiction of cancer stem cells.

Sahoo O, Pethusamy K, Srivastava T, Talukdar J, AlQahtani M, Abbas M Front Oncol. 2022; 12:955892.

PMID: 35957877 PMC: 9357939. DOI: 10.3389/fonc.2022.955892.

References

Sarrio D, Moreno-Bueno G, Hardisson D, Sanchez-Estevez C, Guo M, Herman J . Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int J Cancer. 2003; 106(2):208-15. DOI: 10.1002/ijc.11197. View

Liu S, Dontu G, Wicha M . Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Res. 2005; 7(3):86-95. PMC: 1143566. DOI: 10.1186/bcr1021. View

Lombaerts M, van Wezel T, Philippo K, Dierssen J, Zimmerman R, Oosting J . E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br J Cancer. 2006; 94(5):661-71. PMC: 2361216. DOI: 10.1038/sj.bjc.6602996. View

Cowling V, DCruz C, Chodosh L, Cole M . c-Myc transforms human mammary epithelial cells through repression of the Wnt inhibitors DKK1 and SFRP1. Mol Cell Biol. 2007; 27(14):5135-46. PMC: 1951955. DOI: 10.1128/MCB.02282-06. View

Wissmann C, Wild P, Kaiser S, Roepcke S, Stoehr R, Woenckhaus M . WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol. 2003; 201(2):204-12. DOI: 10.1002/path.1449. View

Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S . Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene. 2006; 25(12):1696-708. DOI: 10.1038/sj.onc.1209327. View

Bilic J, Huang Y, Davidson G, Zimmermann T, Cruciat C, Bienz M . Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation. Science. 2007; 316(5831):1619-22. DOI: 10.1126/science.1137065. View

Ryo A, Nakamura M, Wulf G, Liou Y, Lu K . Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat Cell Biol. 2001; 3(9):793-801. DOI: 10.1038/ncb0901-793. View

Mohinta S, Wu H, Chaurasia P, Watabe K . Wnt pathway and breast cancer. Front Biosci. 2007; 12:4020-33. DOI: 10.2741/2368. View

10.

Aguilera O, Munoz A, Esteller M, Fraga M . Epigenetic alterations of the Wnt/beta-catenin pathway in human disease. Endocr Metab Immune Disord Drug Targets. 2007; 7(1):13-21. DOI: 10.2174/187153007780059450. View

11.

Robertson K . DNA methylation and human disease. Nat Rev Genet. 2005; 6(8):597-610. DOI: 10.1038/nrg1655. View

12.

Gordon M, Nusse R . Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem. 2006; 281(32):22429-33. DOI: 10.1074/jbc.R600015200. View

13.

Chim C, Pang R, Fung T, Choi C, Liang R . Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma. Leukemia. 2007; 21(12):2527-36. DOI: 10.1038/sj.leu.2404939. View

14.

Ai L, Tao Q, Zhong S, Fields C, Kim W, Lee M . Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer. Carcinogenesis. 2006; 27(7):1341-8. DOI: 10.1093/carcin/bgi379. View

15.

Furuuchi K, Tada M, Yamada H, Kataoka A, Furuuchi N, Hamada J . Somatic mutations of the APC gene in primary breast cancers. Am J Pathol. 2000; 156(6):1997-2005. PMC: 1850076. DOI: 10.1016/s0002-9440(10)65072-9. View

16.

Klopocki E, Kristiansen G, Wild P, Klaman I, Castanos-Velez E, Singer G . Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors. Int J Oncol. 2004; 25(3):641-9. View

17.

Suzuki H, Toyota M, Carraway H, Caraway H, Gabrielson E, Ohmura T . Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. Br J Cancer. 2008; 98(6):1147-56. PMC: 2275475. DOI: 10.1038/sj.bjc.6604259. View

18.

Agrawal A, Murphy R, Agrawal D . DNA methylation in breast and colorectal cancers. Mod Pathol. 2007; 20(7):711-21. DOI: 10.1038/modpathol.3800822. View

19.

Ugolini F, Adelaide J, Charafe-Jauffret E, Nguyen C, Jacquemier J, Jordan B . Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes. Oncogene. 1999; 18(10):1903-10. DOI: 10.1038/sj.onc.1202739. View

20.

Bastian P, Ellinger J, Wellmann A, Wernert N, Heukamp L, Muller S . Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci. Clin Cancer Res. 2005; 11(11):4097-106. DOI: 10.1158/1078-0432.CCR-04-1832. View